MentionFox
Home › funding signals › Dragon Vascular, Inc.
Form D · on the record

Dragon Vascular — $18.89M Form D filing, November 2025

Dragon Vascular, Inc. filed a Form D with the Securities and Exchange Commission on 2025-11-03.

Dragon Vascular, Inc. filed a Form D notice of an exempt securities offering with the SEC on November 3, 2025. The filing reports $18.89M sold. Its industry group is Other Health Care. It names Erik Engelson (Executive Officer, Director), Eric Moessinger (Director) (SEC Form D, November 3, 2025).

3 more Other Health Care raises in California, November 2025 ↓

Is this your company?

Key facts

Run the free check on Dragon Vascular, Inc. →

Sell to companies like Dragon Vascular, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Dragon Vascular, Inc.

New Form D on file · 2025-11-03 · the record

$18.89M
raise on the record
D
filing
42
investors in
CALIFORNIA
based
Open the record →

What the record says

FilingForm D
Filed2025-11-03
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
Year formed2024
BasedFREMONT, CALIFORNIA
CIK2080773
Accession0001231919-25-000400

Pitching, partnering or investing alongside them? See who really runs and owns Dragon Vascular, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Dragon Vascular, Inc., from the filings we hold.

More raises like this

Other Health Care raises by companies based in California, filed in November 2025, largest first.

What do you want to do with Dragon Vascular, Inc.?

Get the full cited report on Dragon Vascular, Inc.

What the filing shows about Dragon Vascular, Inc.

  • 42 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Dragon Vascular, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Dragon Vascular, Inc.'s address as 48383 Fremont Blvd., Suite 122, Fremont, CA 94538.

What the filing says

  • Offered: $25,499,992. Sold: $18,894,995. Left to sell: $6,604,997. (filing)
  • Investors: 42 had already invested. (filing)
  • Date of first sale: October 17, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • Securities that converted: the filing says “Total Amount Sold includes conversion of outstanding convertible securities in the amount of $7,500,000.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Dragon Vascular, Inc. See pricing

Is Dragon Vascular, Inc. a real, registered company?

Dragon Vascular, Inc. is a registered filer with the SEC (CIK 2080773) and has filed since 2025-11-03. 1 filing is on record, the latest on 2025-11-03.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Dragon Vascular, Inc.?

Dragon Vascular, Inc.'s Form D of 2025-11-03 names Erik Engelson and Eric Moessinger as its officers, directors or promoters.

How much has Dragon Vascular, Inc. raised?

Its new offerings report $18.89M sold across 1 offering, as its own filings state.

Other Health Care · by week
This raise, $18.89M, filed week of Nov 3

Trailing twelve months. 871 filings in Other Health Care, totalled by week. The dot is this raise, $18.89M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Dragon Vascular, Inc.?

What the filing shows about Dragon Vascular, Inc.

  • 42 investors had already put money in when it filed.
  • The filing names 2 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Dragon Vascular, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Dragon Vascular, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Dragon Vascular, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Dragon Vascular, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Dragon Vascular, Inc.: Raised $18.89M, Form D filed 2025-11-03
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/dragon-vascular-inc-form-d-25000001
Last updated 2026-10-29
Primary record: SEC filing 1 · SEC filing 2
Dragon Vascular raised $18.89M — SEC Form D filing, November 2025. MentionFox, 2026-10-29. https://mentionfox.com/funding/dragon-vascular-inc-form-d-25000001